A paradigm shift from surgical to transcutaneous aortic valve replacement (PARTNER 3 and Evolut Low Risk trials).

David P Taggart

https://doi.org/10.1093/cvr/cvz195

Copy DOI

Journal: Cardiovascular research	Publication Date: Aug 22, 2019
Citations: 2

Abstract

A paradigm shift from surgical to transcutaneous aortic valve replacement (PARTNER 3 and Evolut Low Risk trials).

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author